Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Vicaut

Showing results (431-440 of 522) with videos related to

Pageof 53
Sort By:
The Lancet. Neurology|September 17, 2022
Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort studyCristina Hobeanu, Philippa C Lavallée, Hugo Charles, et al.
Thrombosis Journal|June 2, 2018
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
The Canadian Journal of Cardiology|September 3, 2023
P2Y<sub>12</sub> Inhibitor Loading Time Before Elective PCI and the Prevention of Myocardial NecrosisVincent Roule, Farzin Beygui, Guillaume Cayla, et al.
Journal of the American College of Cardiology|April 23, 2016
Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical TrialFarzin Beygui, Guillaume Cayla, Vincent Roule, et al.
Thrombosis Journal|May 3, 2018
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
Lancet (London, England)|August 23, 2011
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trialGilles Montalescot, Uwe Zeymer, Johanne Silvain, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 16, 2017
Specificities of Ischemic Stroke Risk Factors in Arab-Speaking CountriesHalim Abboud, Leila Sissani, Julien Labreuche, et al.
Annals of Surgery|October 1, 2019
Penetrating Crohn Disease Is Not Associated With a Higher Risk of Recurrence After Surgery: A Prospective Nationwide Cohort Conducted by the Getaid Chirurgie GroupLéon Maggiori, Antoine Brouquet, Philippe Zerbib, et al.
Gut|November 25, 2024
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trialAurelien Amiot, Philippe Seksik, Antoine Meyer, et al.
Annals of Surgery|January 5, 2018
Anti-TNF Therapy Is Associated With an Increased Risk of Postoperative Morbidity After Surgery for Ileocolonic Crohn Disease: Results of a Prospective Nationwide CohortAntoine Brouquet, Léon Maggiori, Philippe Zerbib, et al.
Pageof 53

Showing results (431-440 of 522) with videos related to

Sort By:
Pageof 53
The Lancet. Neurology|September 17, 2022
Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort studyCristina Hobeanu, Philippa C Lavallée, Hugo Charles, et al.
Thrombosis Journal|June 2, 2018
Correction to: Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
The Canadian Journal of Cardiology|September 3, 2023
P2Y<sub>12</sub> Inhibitor Loading Time Before Elective PCI and the Prevention of Myocardial NecrosisVincent Roule, Farzin Beygui, Guillaume Cayla, et al.
Journal of the American College of Cardiology|April 23, 2016
Early Aldosterone Blockade in Acute Myocardial Infarction: The ALBATROSS Randomized Clinical TrialFarzin Beygui, Guillaume Cayla, Vincent Roule, et al.
Thrombosis Journal|May 3, 2018
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) studyAlexander T Cohen, Cihan Ay, Philippe Hainaut, et al.
Lancet (London, England)|August 23, 2011
Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trialGilles Montalescot, Uwe Zeymer, Johanne Silvain, et al.
Cerebrovascular Diseases (Basel, Switzerland)|February 16, 2017
Specificities of Ischemic Stroke Risk Factors in Arab-Speaking CountriesHalim Abboud, Leila Sissani, Julien Labreuche, et al.
Annals of Surgery|October 1, 2019
Penetrating Crohn Disease Is Not Associated With a Higher Risk of Recurrence After Surgery: A Prospective Nationwide Cohort Conducted by the Getaid Chirurgie GroupLéon Maggiori, Antoine Brouquet, Philippe Zerbib, et al.
Gut|November 25, 2024
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trialAurelien Amiot, Philippe Seksik, Antoine Meyer, et al.
Annals of Surgery|January 5, 2018
Anti-TNF Therapy Is Associated With an Increased Risk of Postoperative Morbidity After Surgery for Ileocolonic Crohn Disease: Results of a Prospective Nationwide CohortAntoine Brouquet, Léon Maggiori, Philippe Zerbib, et al.
Pageof 53